Alert! This chapter may be affected by an emergency rule:
Register June 2016 No. 726
Chapter CSB 4
CSB 4.01   Authority and scope.
CSB 4.02   Definitions.
CSB 4.03   Drugs that have a substantial potential for abuse.
CSB 4.04   Compilation of dispensing data.
CSB 4.05   Electronic submission of dispensing data.
CSB 4.06   Frequency of submissions.
CSB 4.07   Correction of dispensing data.
CSB 4.08   Exemptions from compiling and submitting dispensing data.
CSB 4.09   Direct access to PDMP information.
CSB 4.10   Requests for review.
CSB 4.11   Methods of obtaining PDMP information.
CSB 4.12   Use of PDMP information by the board and department.
CSB 4.13   Confidentiality of PDMP information.
CSB 4.14   Exchange of PDMP information.
CSB 4.15   Disclosure of suspicious or critically dangerous conduct or practices.
Ch. CSB 4 Note Note: Chapter Phar 18 was renumbered chapter CSB 4 under s. 13.92 (4) (b) 1., Stats., Register September 2015 No. 717.
CSB 4.01 CSB 4.01Authority and scope. The rules in this chapter are adopted under authority in ss. 227.11 (2) (a) and 961.385, Stats., for the purpose of creating a prescription drug monitoring program to collect and maintain information relating to the prescribing and dispensing of prescription drugs.
CSB 4.01 History History: CR 12-009: cr. Register October 2012 No. 682, eff. 1-1-13; correction made under s. 13.92 (4) (b) 7., Stats., Register September 2015 No. 717.
CSB 4.02 CSB 4.02Definitions. As used in this chapter:
CSB 4.02(1) (1) “Access" means to have the ability to view PDMP information through an account established with the board.
CSB 4.02(2) (2) “Administer" has the meaning given in s. 450.01 (1), Stats.
CSB 4.02(3) (3) “Animal" has the meaning given in s. 89.02 (1m), Stats.
CSB 4.02(3m) (3m) “ASAP" means the American Society for Automation in Pharmacy.
CSB 4.02 Note Note: Contact: American Society for Automation in Pharmacy, 492 Norristown Road, Suite 160; Blue Bell, PA 19422; phone: (610) 825-7783; fax: (610) 825-7641; webpage:
CSB 4.02(4) (4) “Board" means the Controlled Substances Board.
CSB 4.02(5) (5) “Controlled substance" means a drug, substance, analog, or precursor described in any of the following:
CSB 4.02(5)(a) (a) Schedule I, II, III, IV, or V in the federal controlled substances act, 21 USC 812 (b) (1) to (b) (5) and (c), as changed and updated by 21 CFR 1308.
CSB 4.02(5)(b) (b) Schedule I, II, III, IV, or V in subch. II of ch. 961, Stats., as amended by ch. CSB 2.
CSB 4.02(6) (6) “Department" means the department of safety and professional services.
CSB 4.02(7) (7) “Dispense" has the meaning given in s. 450.01 (7), Stats.
CSB 4.02(8) (8) “Dispenser" means all of the following:
CSB 4.02(8)(a) (a) A pharmacy.
CSB 4.02 Note Note: A site of remote dispensing authorized under s. 450.062, Stats., and s. Phar 7.095 is under the supervision of a pharmacy.
CSB 4.02(8)(b) (b) A practitioner who dispenses a monitored prescription drug.
CSB 4.02(9) (9) “Dispenser delegate" means any of the following:
CSB 4.02(9)(a) (a) A managing pharmacist of a pharmacy.
CSB 4.02(9)(b) (b) An agent or employee of a practitioner who has been delegated the task of satisfying the data compilation and submission requirements of ss. CSB 4.04 and 4.05.
CSB 4.02(10) (10) “Dispensing data" means data compiled pursuant to s. CSB 4.04.
CSB 4.02(11) (11) “Drug" has the meaning given in s. 450.01 (10), Stats.
CSB 4.02(11g) (11g) “Hospital" has the meaning given in s. 50.33 (2), Stats.
CSB 4.02(11r) (11r) “Managing pharmacist" has the meaning given in s. Phar 1.02 (6).
CSB 4.02(12) (12)
CSB 4.02(12)(a)(a) “Monitored prescription drug" means all of the following:
CSB 4.02(12)(a)1. 1. A controlled substance included in s. 961.385 (1), Stats.
CSB 4.02(12)(a)2. 2. A drug identified by the board as having a substantial potential for abuse in s. CSB 4.03.
CSB 4.02(12)(b) (b) “Monitored prescription drug" does not mean a controlled substance that by law may be dispensed without a prescription order.
CSB 4.02(13) (13) “Patient" has the meaning given in s. 450.01 (14), Stats.
CSB 4.02(14) (14) “Person authorized by the patient" means person authorized by the patient in s. 146.81 (5), Stats., and includes persons with delegated authority under s. 48.979, Stats.
CSB 4.02(14e) (14e) “PDMP" means the Wisconsin prescription drug monitoring program.
CSB 4.02(15) (15) “PDMP information" means any of the following:
CSB 4.02(15)(a) (a) The data compiled and stored by the board from dispensing data submitted to it by dispensers.
CSB 4.02(15)(b) (b) The information created by the board to satisfy the requirements in s. CSB 4.12.
CSB 4.02(15g) (15g) “Pharmacist" has the meaning given in s. 961.385 (1) (aL), Stats.
CSB 4.02(15r) (15r) “Pharmacist delegate" means an agent of a pharmacist to whom the pharmacist has delegated the task of accessing PDMP information.
CSB 4.02(16) (16) “Pharmacy" means any place of practice licensed by the board under ss. 450.06 or 450.065, Stats., including a pharmacy that chooses to solely dispense to animal patients.
Published under s. 35.93, Stats. Updated on the first day of each month. Entire code is always current. The Register date on each page is the date the chapter was last published.